Stay updated on ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The NIH transition announcement about site updates and the use of “Super Intelligence” terminology is no longer displayed in the page banner.
    Difference
    1%
    Check dated 2026-11-08T13:00:25.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:34:06.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says federal agencies are adopting “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T13:23:18.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page footer now shows revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T13:38:59.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T13:41:05.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the study record content with an access-denied page. This prevents viewing the trial's details and related information.
    Difference
    20%
    Check dated 2026-09-20T20:13:02.000Z thumbnail image

Stay in the know with updates to ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.